Antiarrhythmic drug approval--the Health Protection Branch perspective.
Znamirowska
M
M
Cardiovascular Division, Bureau of Human Prescription Drugs, Ottawa, Ontario.
D000889:Anti-Arrhythmia Agents; D002170:Canada; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence* / Q000592:standards; D004341:Drug Evaluation / Q000592:standards*; D015507:Drugs, Investigational; D006077:Government Agencies; D006801:Humans
D000889:Anti-Arrhythmia Agents; D015507:Drugs, Investigational